FR2394527A1 - N- (3'-PHENYLTHIOPROPYL) -3,3-DIPHENYLPROPYLAMINES SUBSTITUTED WITH PHARMACOLOGICAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents

N- (3'-PHENYLTHIOPROPYL) -3,3-DIPHENYLPROPYLAMINES SUBSTITUTED WITH PHARMACOLOGICAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Info

Publication number
FR2394527A1
FR2394527A1 FR7817593A FR7817593A FR2394527A1 FR 2394527 A1 FR2394527 A1 FR 2394527A1 FR 7817593 A FR7817593 A FR 7817593A FR 7817593 A FR7817593 A FR 7817593A FR 2394527 A1 FR2394527 A1 FR 2394527A1
Authority
FR
France
Prior art keywords
diphenylpropylamines
phenylthiopropyl
substituted
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7817593A
Other languages
French (fr)
Other versions
FR2394527B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfa Farmaceutici SpA
Original Assignee
Alfa Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Farmaceutici SpA filed Critical Alfa Farmaceutici SpA
Publication of FR2394527A1 publication Critical patent/FR2394527A1/en
Application granted granted Critical
Publication of FR2394527B1 publication Critical patent/FR2394527B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Ces produits sont ceux de la formule (1) dans laquelle R représente un hydrogène ou un groupe alcoyle contenant à à 4 atomes de carbone; R', R'', R''' et R'''', semblables ou différents les uns des autres, représentent des atomes d'hydrogène ou des groupes OH, avec cette limitation que quand R', R'', R''' et R'''' sont tous des atomes d'hydrogène, R ne peut pas être un atome d'hydrogène, et leurs sels avec des acides organiques et inorganiques acceptables pharmaceutiquement. Application : médicaments utilisables comme drogues antiulcéreuses, antispasmodiques et/ou spasmolytiques.These products are those of formula (1) in which R represents a hydrogen or an alkyl group containing from 4 to 4 carbon atoms; R ', R' ', R' '' and R '' '', similar or different from each other, represent hydrogen atoms or OH groups, with this limitation that when R ', R' ', R '' 'and R' '' 'are all hydrogen atoms, R cannot be hydrogen, and their salts with pharmaceutically acceptable organic and inorganic acids. Application: medicaments which can be used as antiulcer, antispasmodic and / or spasmolytic drugs.

FR7817593A 1977-06-17 1978-06-13 N- (3'-PHENYLTHIOPROPYL) -3,3-DIPHENYLPROPYLAMINES SUBSTITUTED WITH PHARMACOLOGICAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Granted FR2394527A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT03474/77A IT1080455B (en) 1977-06-17 1977-06-17 N 3 FENILTIOPROPIL 3.3 DIPHENYL REPLACED PROPILAMINS EQUIPPED WITH PHARMACOLOGY ACTIVITIES

Publications (2)

Publication Number Publication Date
FR2394527A1 true FR2394527A1 (en) 1979-01-12
FR2394527B1 FR2394527B1 (en) 1980-06-20

Family

ID=11108046

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7817593A Granted FR2394527A1 (en) 1977-06-17 1978-06-13 N- (3'-PHENYLTHIOPROPYL) -3,3-DIPHENYLPROPYLAMINES SUBSTITUTED WITH PHARMACOLOGICAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Country Status (14)

Country Link
JP (1) JPS5430142A (en)
AT (1) AT357141B (en)
BE (1) BE867570A (en)
DE (1) DE2825447A1 (en)
DK (1) DK144064C (en)
ES (1) ES470845A1 (en)
FR (1) FR2394527A1 (en)
GB (1) GB1561679A (en)
GR (1) GR73140B (en)
IT (1) IT1080455B (en)
NL (1) NL7805617A (en)
NO (1) NO145097C (en)
PT (1) PT68122A (en)
SE (1) SE7806945L (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2015197C (en) * 1990-04-23 1999-08-24 Kowichi Jimbow Phenolic amine depigmenting and antimelanoma agents
US5395611A (en) * 1990-04-24 1995-03-07 The Governors Of The University Of Alberta Phenolic amine depigmenting and antimelanoma agents

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2145639A1 (en) * 1971-07-15 1973-02-23 Alfa Farmaceutici Spa

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2145639A1 (en) * 1971-07-15 1973-02-23 Alfa Farmaceutici Spa

Also Published As

Publication number Publication date
DK144064C (en) 1982-06-21
NO145097B (en) 1981-10-05
GB1561679A (en) 1980-02-27
ATA430078A (en) 1979-11-15
BE867570A (en) 1978-09-18
PT68122A (en) 1978-06-01
ES470845A1 (en) 1979-09-01
SE7806945L (en) 1978-12-18
DK144064B (en) 1981-11-30
FR2394527B1 (en) 1980-06-20
JPS5430142A (en) 1979-03-06
NO145097C (en) 1982-01-13
IT1080455B (en) 1985-05-16
AT357141B (en) 1980-06-25
NO782101L (en) 1978-12-19
GR73140B (en) 1984-02-08
DE2825447A1 (en) 1979-01-04
DK269278A (en) 1978-12-18
NL7805617A (en) 1978-12-19

Similar Documents

Publication Publication Date Title
EP0241809B1 (en) Synergistic association of amantadine and selegiline
FR2439187A1 (en) SUBSTITUTED 1-PIPERAZINE-CARBOXAMIDES AND -CARBOTHIOAMIDES DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CA2310141A1 (en) Use of sulphinyl benzhydryl derivatives for treating drug-induced sleepiness
BE902897A (en) 3-AMINOPROPOXYARYL DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS DRUGS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN92008A1 (en) NEW STEROIDS-ESTERS
BE900345A (en) OPHTHALMIC PHARMACEUTICAL COMPOSITION BASED ON A PHENYLACETIC ACID DERIVATIVE.
FR2361901A1 (en) NUCLEOTIDES SUBSTITUTION DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
BE904796A (en) NOVEL MORPHINANE AND MORPHINE DERIVATIVES, THEIR PREPARATION, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
GB2188547A (en) Tamoxifen preparation
NL8204126A (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION WITH A LOCAL ANESTHETIC EFFECT CONTAINING A DIALYLAMINO-2 ', 6'-ACETOXYLIDIDE AND / OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND THE PREPARED PROPERTY OF THESE PREPARED THEREFORE THEREFORE DIALKYLAMINO-2 ', 6'ACETOXYLIDIDS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS.
EP0003056A1 (en) N-substituted omega-aminoalkanoyl-omega-aminoalkanecarboxylic acids, their application and process for their preparation, and medicines containing these compounds
GB2184653A (en) Dementia improving and therapeutic agents
Hirschberg et al. Laboratory evaluation of a new nitrogen mustard, 2-[di-(2-chloroethyl) aminomethyl] benzimidazole, and of other 2-chloroethyl compounds
EP0068998B1 (en) (z)-1-aryl-2-aminomethyl-cyclopropane-carboxylates, their preparation and their use as medicines in the treatment of various disorders
DE2727047A1 (en) INDOL DERIVATIVES, PROCESS FOR THEIR MANUFACTURING AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
KR910700230A (en) New hydroxylamine derivatives
BE902586A (en) COMPOUNDS WITH ANTIBACTERIAL ACTIVITY, THEIR MANUFACTURING METHOD AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME.
FR2394527A1 (en) N- (3'-PHENYLTHIOPROPYL) -3,3-DIPHENYLPROPYLAMINES SUBSTITUTED WITH PHARMACOLOGICAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US2278123A (en) Antispasmodics
Kosaki et al. Marine toxins from the Pacific—IV Pharmacology of ciguatoxin (s)
JPS63258415A (en) Immunostimulant drug containing n-substituted- 2-cyanaziridine
US3577551A (en) Methods for treating pain,inflammation and cough
DE1618849B1 (en) Phenylisopropylamide compounds and processes for their preparation
FR2457868A1 (en) IMIDAZOBENZODIAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
BE1002696A3 (en) DIOXAZOCIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Legal Events

Date Code Title Description
ST Notification of lapse